Last updated on October 2017

Real World Data on Gi(l)Otrif Dose Adjustment

Brief description of study

This is a non-interventional, multi-country, multi-site study based on existing data from medical records of patients treated with Gi(l)otrif® as part of the routine treatment according to the approved label. Data from real-world will help to understand if dose modifications are done similar as in LUX-Lung 3 trial and if the outcome on safety and effectiveness are as in trial settings. Furthermore, data on modified starting doses, the underlying reasons and effects on safety and outcome are needed.

Clinical Study Identifier: NCT02751879

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim Call Center

Chonbuk National University Hospital
Jeonju, Korea, Republic of
  Connect »